Form 4: CVS Health Executive Heidi Capozzi Reports Acquisition of Restricted Stock and Stock Options
SEC Form 4 Filing
EVP and Chief People Officer of CVS Health, Heidi B. Capozzi, reports the acquisition of restricted stock units and stock options.
Summary
- Heidi B. Capozzi, EVP and Chief People Officer of CVS Health, filed a Form 4 on April 3, 2025, reporting changes in beneficial ownership.
- On April 1, 2025, Capozzi acquired 11,768 shares of restricted common stock at a price of $67.98 per share.
- Following this transaction, Capozzi directly owns 95,310 shares of common stock.
- Capozzi also acquired stock options for 49,906 shares of common stock with an exercise price of $67.98, exercisable in four equal annual installments commencing April 1, 2026.
- These restricted stock units were awarded pursuant to the Issuer's 2017 Incentive Compensation Plan and lapse in four equal installments, commencing 4/1/2026.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of stock and option awards to an executive, which doesn't inherently indicate positive or negative sentiment about the company's prospects.
Positives
- The acquisition of restricted stock and stock options by a high-ranking executive could be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The document does not contain specific forward-looking statements about the company's future performance, but the vesting schedule of the restricted stock and stock options suggests a multi-year incentive plan for the executive.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge executive sentiment and potential future stock performance.
Stakeholder Impact
- The acquisition of shares by an executive can signal confidence to shareholders.
- The incentive plan may motivate the executive to improve company performance, benefiting stakeholders.
Key Dates
| Date | Description |
|---|---|
| 04/01/2025 | Date of transaction: Acquisition of restricted stock and stock options. |
| 04/01/2026 | Commencement date for vesting of restricted stock units and exercisability of stock options. |
| 04/03/2025 | Date of Form 4 filing. |
| 04/01/2035 | Expiration date for stock options. |
Keywords
Form 4, CVS Health, Stock Options, Restricted Stock, Beneficial Ownership, Heidi Capozzi, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.